ENLIVEN THERAPEUTICS INC ELVN
COM · Common Stock · CUSIP 29337E102
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersBurlingame, CA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($22.8k this quarter). Holder counts are more reliable. Shares outstanding: 41.1m as of 2023-05-01, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $21.88. Options: 3 managers hold calls ($8.2m notional), 1 hold puts ($5.5k).
Trends to Q1 2023
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2022 | $0 | $0 | — |
| Q4 2022 | $0 | $0 | — |
| Q1 2023 | $8.2m | $5.5k | 0.00 |
Biggest buyers
| ORBIMED ADVISORS LLC | New | +9.0m |
| FMR LLC | New | +6.3m |
| 5AM Venture Management, LLC | New | +5.8m |
| CITADEL ADVISORS LLC | New | +2.3m |
| Venrock Adviser, LLC | New | +2.2m |
| RA CAPITAL MANAGEMENT, L.P. | New | +2.1m |
| Cormorant Asset Management, LP | New | +1.9m |
| Fairmount Funds Management LLC | New | +1.9m |
| Commodore Capital LP | New | +1.7m |
| Frazier Life Sciences Management, L.P. | New | +831.0k |
Biggest sellers
| None |
Biggest calls
| GROUP ONE TRADING LLC | New | $4.2m192.7k shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | New | $3.9m179.5k shares |
| CITADEL ADVISORS LLC | New | $55.3k2.5k shares |
Biggest puts
| CITADEL ADVISORS LLC | New | $5.5k250 shares |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| FMR LLC 13G · institution +1.7 pts · filed 2026-08-06 | 15.0% |
ORBIMED ADVISORS LLC
13D · may seek influence
-1.4 pts · filed 2026-06-24
Stated purposeThe Reporting Persons from time to time intend to review their investment in the Issuer on the basis of various factors, including the Issuer's business, financial condition, results of operations and prospects, general economic and industry conditions, the securities markets in general and those for the Issuer's Shares in particular, as well as other developments and other investment opportunities. Based upon such review, the Reporting Persons will take such actions in the future as the Reporting Persons may deem appropriate in light of the circumstances existing from time to time. If the Reporting Persons believe that further investment in the Issuer is attractive, whether because of the market price of Shares or otherwise, they may acquire Shares or other securities of the Issuer either… Full filing |
9.5% |
| Polar Capital Holdings Plc 13G · institution no change · filed 2026-06-22 | 8.5% |
| Commodore Capital LP 13G · passive investor -2.2 pts · filed 2026-05-15 | 7.7% |
| BlackRock, Inc. 13G · institution +2.0 pts · filed 2026-10-27 | 7.1% |
| Vestal Point Capital, LP 13G · institution -1.1 pts · filed 2026-05-15 | 5.4% |
Fell to 5% or below in the last year: Venrock Healthcare Capital Partners III, L.P. (2.8%, 2026-05-15), Fairmount Funds Management LLC (3.1%, 2026-05-15)
Insider purchases and sales in Q1 2023
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q2 2021 | 0 | — | 0 | — | — |
| Q3 2021 | 0 | — | 0 | — | — |
| Q4 2021 | 0 | — | 1 | $159.4k | — |
| Q1 2022 | 1 | $313.6k | 0 | — | — |
| Q2 2022 | 0 | — | 0 | — | — |
| Q3 2022 | 0 | — | 0 | — | — |
| Q4 2022 | 0 | — | 0 | — | — |
| Q1 2023 | 0 | — | 2 | $199.2k | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2023-02-23 | COMMODORE CAPITAL LP 10% owner · By Commodore Capital Master LP | Bought | $13.7k622 shares |
| 2023-02-22 | Ballal Rahul D. Chief Executive Officer | Sold | $153.1k32.9k shares |
| 2023-02-22 | COMMODORE CAPITAL LP 10% owner · By Commodore Capital Master LP | Bought | $120.4k23.6k shares |
| 2023-02-22 | GRAY MICHAEL CFO & COO | Sold | $46.0k9.9k shares |
| 2023-02-21 | COMMODORE CAPITAL LP 10% owner · By Commodore Capital Master LP | Bought | $43.0k8.2k shares |
| 2023-01-30 | Ballal Rahul D. Chief Executive Officer | Sold | —11.3k shares |
| 2023-01-30 | GRAY MICHAEL CFO & COO | Sold | —3.6k shares |
| 2023-01-03 | RA Capital Healthcare Fund LP +3 10% owner · See Footnotes | Bought | —629.3k shares |
| 2023-01-03 | Leonard Braden Michael 10% owner · Holding of BML Investment Partners, L.P. | Sold | —1.2m shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q1 2023
| Manager | Shares | Change |
|---|---|---|
| ORBIMED ADVISORS LLC 3.90% of their portfolio | 9.0m $197.0m | New |
| FMR LLC 0.01% of their portfolio | 6.3m $138.6m | New |
| 5AM Venture Management, LLC 32.47% of their portfolio | 5.8m $127.0m | New |
| CITADEL ADVISORS LLC 0.05% of their portfolio | 2.3m $50.3m | New |
| Venrock Adviser, LLC 9.47% of their portfolio | 2.2m $48.5m | New |
| RA CAPITAL MANAGEMENT, L.P. 1.05% of their portfolio | 2.1m $46.5m | New |
| Cormorant Asset Management, LP 2.79% of their portfolio | 1.9m $42.4m | New |
| Fairmount Funds Management LLC 7.25% of their portfolio | 1.9m $42.2m | New |
| Commodore Capital LP 5.77% of their portfolio | 1.7m $37.9m | New |
| Frazier Life Sciences Management, L.P. 1.32% of their portfolio | 831.0k $18.2m | New |
| Boxer Capital, LLC 0.76% of their portfolio | 710.6k $15.6m | New |
| JANUS HENDERSON GROUP PLC 0.01% of their portfolio | 602.2k $13.2m | New |
| Logos Global Management LP 1.26% of their portfolio | 401.2k $8.8m | New |
| BML Capital Management, LLC 4.02% of their portfolio | 212.2k $4.6m | New |
| VANGUARD GROUP INC 0.00% of their portfolio | 151.9k $3.3m | New |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 70.3k $1.5m | New |
| JBF Capital, Inc. 0.25% of their portfolio | 50.0k $1.1m | New |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 46.9k $1.0m | New |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 41.4k $906.9k | New |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 35.4k $775.0k | New |
| PRELUDE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 34.1k $40.0k | New |
| BlackRock Inc. 0.00% of their portfolio | 33.8k $740.1k | New |
| ACUTA CAPITAL PARTNERS, LLC 0.53% of their portfolio | 31.0k $678.4k | New |
| JANE STREET GROUP, LLC 0.00% of their portfolio | 18.4k $403.9k | New |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.01% of their portfolio | 17.9k $393.1k | New |
| MORGAN STANLEY 0.00% of their portfolio | 17.4k $381.5k | New |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% of their portfolio | 17.2k $376.0k | New |
| Bank of New York Mellon Corp 0.00% of their portfolio | 15.3k $335.0k | New |
| MIRABELLA FINANCIAL SERVICES LLP 0.04% of their portfolio | 11.7k $255.6k | New |
| CITIGROUP INC 0.00% of their portfolio | 11.3k $246.7k | New |
| DIMENSIONAL FUND ADVISORS LP 0.00% of their portfolio | 9.9k $217.1k | New |
| STATE STREET CORP 0.00% of their portfolio | 9.4k $206.4k | New |
| Cubist Systematic Strategies, LLC 0.00% of their portfolio | 9.0k $196.8k | New |
| BARCLAYS PLC 0.00% of their portfolio | 7.2k $158.3k | New |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 6.5k $143.3k | New |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 1.7k $36.0k | New |
| Dorsey Wright & Associates 0.01% of their portfolio | 1.2k $27.1k | New |
| Point72 Asset Management, L.P. 0.00% of their portfolio | 746 $16.3k | New |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 486 $11.0k | New |
| UBS Group AG 0.00% of their portfolio | 334 $7.3k | New |
| Point72 Middle East FZE 0.00% of their portfolio | 293 $6.4k | New |
| FEDERATED HERMES, INC. 0.00% of their portfolio | 243 $5.3k | New |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 94 $2.0k | New |
| Mariner Managed Account Solutions, LLC 0.00% of their portfolio | 50 $1.1k | New |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 24 $526 | New |